[1]
J. Balapradhana Santoso, “Cost Effectiveness Analysis Trastuzumab Deruxtecan Versus Trastuzumab Emtansine Pada Pasien Kanker Payudara Metastatik Her2-Positif: Systematic Review”, IJHET, vol. 4, no. 6, Mar. 2026.